AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
Log in

NASDAQ:PRQRProQR Therapeutics SEC Filings & 10K Form

$5.56
-0.04 (-0.71 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$5.43
Now: $5.56
$5.63
50-Day Range
$4.64
MA: $5.18
$5.87
52-Week Range
$4.46
Now: $5.56
$12.60
Volume101,688 shs
Average Volume206,020 shs
Market Capitalization$276.59 million
P/E RatioN/A
Dividend YieldN/A
Beta0.5

SEC Filings

ProQR Therapeutics (NASDAQ:PRQR) SEC Filings

DateFilerForm TypeView
05/07/2020
6:31 AM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/31/2020
4:06 PM
ProQR Therapeutics (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/31/2020
3:49 PM
ProQR Therapeutics (Filer)
Form 424B5
03/31/2020
6:11 AM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2020
6:52 AM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2020
12:47 PM
ProQR Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/12/2020
3:11 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
ProQR Therapeutics (Subject)
Form SC 13G/A
02/11/2020
6:00 AM
ProQR Therapeutics (Subject)
UBS Group AG (Filed by)
Form SC 13G/A
02/03/2020
8:45 AM
ProQR Therapeutics (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G/A
01/30/2020
8:12 AM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/29/2020
2:31 PM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
ProQR Therapeutics (Subject)
Form SC 13G/A
01/28/2020
10:34 AM
ProQR Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/27/2020
4:21 PM
Inspirational Visions B.V. (Filed by)
ProQR Therapeutics (Subject)
Form SC 13G/A
12/11/2019
7:46 AM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/21/2019
3:09 PM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/08/2019
8:00 AM
ProQR Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
10/17/2019
3:26 PM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/17/2019
3:22 PM
ProQR Therapeutics (Filer)
Form 424B5
10/16/2019
5:11 AM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/16/2019
5:08 AM
ProQR Therapeutics (Filer)
Form 424B5
10/10/2019
7:05 AM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2019
3:30 PM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/28/2019
3:30 PM
Inspirational Visions B.V. (Filed by)
ProQR Therapeutics (Subject)
Form SC 13G
08/12/2019
3:04 PM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2019
6:55 AM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/29/2019
3:03 PM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2019
3:03 PM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/08/2019
3:13 PM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/23/2019
11:08 AM
ProQR Therapeutics (Filer)
Form CT ORDER
04/15/2019
6:56 AM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/28/2019
8:24 AM
ProQR Therapeutics (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/26/2019
3:11 PM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/11/2019
4:02 PM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/27/2019
7:27 AM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/22/2019
2:34 PM
ProQR Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G
02/15/2019
12:05 PM
ProQR Therapeutics (Subject)
UBS Group AG (Filed by)
Form SC 13G
02/14/2019
10:37 AM
ProQR Therapeutics (Subject)
Sofinnova Partners SAS (Filed by)
Form SC 13G/A
02/14/2019
8:32 AM
ProQR Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/13/2019
12:41 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
ProQR Therapeutics (Subject)
Form SC 13G/A
02/12/2019
3:16 PM
Invus Public Equities, L.P. (Filed by)
ProQR Therapeutics (Subject)
Form SC 13G/A
02/07/2019
4:10 PM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
ProQR Therapeutics (Subject)
Form SC 13G
02/01/2019
1:27 PM
JENNISON ASSOCIATES LLC (Filed by)
ProQR Therapeutics (Subject)
Form SC 13G/A
01/31/2019
3:08 PM
ProQR Therapeutics (Subject)
Form SC 13G/A
01/29/2019
3:31 PM
ProQR Therapeutics (Filer)
Form 6-K/A
01/29/2019
7:47 AM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/18/2019
3:12 PM
Inspirational Visions B.V. (Filed by)
ProQR Therapeutics (Subject)
Form SC 13G/A
01/07/2019
6:05 AM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/13/2018
6:30 AM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/10/2018
3:18 PM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/04/2018
7:38 AM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/19/2018
11:15 PM
ProQR Therapeutics (Filer)
Form EFFECT
11/07/2018
3:55 PM
ProQR Therapeutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
11/07/2018
3:40 PM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2018
3:30 PM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/17/2018
3:37 PM
ProQR Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G
09/07/2018
4:15 PM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/07/2018
4:11 PM
ProQR Therapeutics (Filer)
Form 424B5
09/05/2018
4:02 PM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2018
3:57 PM
ProQR Therapeutics (Filer)
Form 424B5
09/05/2018
7:14 AM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/08/2018
3:37 PM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/29/2018
7:10 AM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/12/2018
4:00 PM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/25/2018
3:27 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
ProQR Therapeutics (Subject)
Form SC 13G
05/10/2018
5:55 AM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/23/2018
6:33 AM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/12/2018
4:29 PM
Aescap Medical Investments B.V. (Filed by)
ProQR Therapeutics (Subject)
Form SC 13G
04/11/2018
10:02 AM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2018
1:56 PM
ProQR Therapeutics (Filer)
Form CT ORDER
03/30/2018
7:03 AM
ProQR Therapeutics (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/28/2018
8:31 AM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2018
3:18 PM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/13/2018
3:47 PM
ORBIMED ADVISORS LLC (Filed by)
ProQR Therapeutics (Subject)
Form SC 13G/A
02/12/2018
3:32 PM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/09/2018
3:25 PM
Invus Public Equities, L.P. (Filed by)
ProQR Therapeutics (Subject)
Form SC 13G
02/06/2018
8:53 AM
JENNISON ASSOCIATES LLC (Filed by)
ProQR Therapeutics (Subject)
Form SC 13G/A
01/26/2018
1:34 PM
ProQR Therapeutics (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G/A
12/29/2017
3:10 PM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/29/2017
3:58 PM
ProQR Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.